Jacobs Levy Equity Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-158,455
| Closed | -$632K | – | 1149 |
|
|
2021
Q3 | $632K | Buy |
158,455
+27,155
| +21% | +$108K | ﹤0.01% | 832 |
|
|
2021
Q2 | $562K | Sell |
131,300
-123
| -0.1% | -$526 | ﹤0.01% | 843 |
|
|
2021
Q1 | $557K | Sell |
131,423
-61,975
| -32% | -$263K | ﹤0.01% | 849 |
|
|
2020
Q4 | $750K | Buy |
193,398
+38,748
| +25% | +$150K | 0.01% | 786 |
|
|
2020
Q3 | $623K | Buy |
154,650
+48,004
| +45% | +$193K | 0.01% | 751 |
|
|
2020
Q2 | $454K | Buy |
106,646
+26,428
| +33% | +$113K | ﹤0.01% | 808 |
|
|
2020
Q1 | $337K | Buy |
80,218
+38,563
| +93% | +$162K | ﹤0.01% | 813 |
|
|
2019
Q4 | $164K | Buy |
+41,655
| New | +$164K | ﹤0.01% | 953 |
|